Surgical Site Infections

https://doi.org/10.1016/j.suc.2014.08.008Get rights and content

Section snippets

Key points

  • Surgical site infections (SSIs) are major contributors to patient morbidity and mortality in hospital settings.

  • Risk for SSI is multifactorial and includes modifiable and nonmodifiable factors.

  • Basic and clinical research has expanded evidence-based guidelines for SSI prevention.

  • SSIs are increasingly used as outcome and surrogate measures for examining the quality of surgical care.

  • A culture of safety and quality is an important element to reducing SSI.

Definitions

To assist with appropriate surveillance of SSIs, establishing clear definitions for cases of SSIs was critical. The Centers for Disease Control and Prevention (CDC) established the National Healthcare Safety Network (NHSN) to monitor quality control measures, including SSIs, and has defined widely used definitions for SSI (Box 1).4 SSI are classified based on the depth of involvement of the infection, which may be confined to the skin and subcutaneous tissues (superficial incisional SSI),

Epidemiology

Recognizing the historical context of surgical infection can highlight the gains that have been made over the past few centuries. Before the antisepsis era, the risk of surgery was exceedingly high due to the enormous rates of surgical infection. Compounded by the absence of the effective anesthesia, early surgical procedures had limited success compared with the modern era. Acknowledgment of the aseptic approach made a significant impact on outcomes. The simple introduction of hand washing by

Risk factors for surgical site infection

From a general perspective, the microbes responsible for infection of surgical wounds originate from either the surrounding skin or associated structures that are contiguous with the regions of the surgical procedure. The logical extension of this principle is that the risk of wound contamination and subsequent SSI depends on location, the nature of the surgical wound/incision, and the procedure performed. The CDC wound classification system defines wound class based on risk and is divided into

Microbial factors

The predominant source of microbes involved in SSIs originate from either the skin or the surrounding tissues of the incision, or from deeper structures involved in the operative procedure (eg, enteric organisms in bowel-related surgeries). In the most recent NHSN surveillance report on 21,100 isolates from 2009 to 2010, the most frequently identified pathogens were, in order, Staphylococcus aureus, Coagulase-negative Staphylococci, Escherichia coli, Enterococcus faecalis, and Pseudomonas

Patient factors

Patient comorbidities can contribute significantly to the potential risk of SSIs. These factors include age, obesity, smoking, diabetes mellitus, malnutrition, dyslipidemia, and immunosuppression (see Box 2).41 These factors are not directly accounted for in the NNIS classification scheme but can contribute significantly to the risk of SSI. Identification of these risk factors with appropriate preoperative history and physical examination is critical. The core principle for management of these

Perioperative factors

Preventative measures in the preoperative period have changed rapidly over the past few decades. A large volume of research has established the importance of a host of preventative measures in the operative period. Examples include skin decontamination, perioperative warming, and antimicrobial prophylaxis.41, 44, 45 As additional studies have been conducted with increasing methodological rigor, from observational studies to randomized controlled trials, refinements of existing preventative

Major limitations in prevention

In an ideal scenario, primary prevention is completely effective and the burden of SSI-related morbidity is reduced to 0%. As described in later discussion, the relationship between compliance with evidence-based guidelines and SSI outcomes is imperfect. With the risk inherent with nonmodifiable risk factors, there will likely be a minimum prevalence that cannot be entirely eliminated. In addition, with the development of numerous evidence-based guidelines, there continue to be hurdles with

Therapy

The general principle of SSI therapy remains control of the source of infection. For superficial SSI, the standard management remains the use of incision and drainage.62, 95 The wound should be sufficiently sized to promote adequate drainage. A variety of local wound care options are available, with the simplest being saline-soaked cotton gauze dressings.62 For uncomplicated superficial SSIs, simple incision and drainage, with local wound care, are appropriate, with no antibiotic therapy

The economic and quality of care impact of surgical site infections

The economic costs of SSIs are significant because of the volumes of cases that are seen, with an annual 2.7 million operative procedures performed in the United States.5 Even with a conservative estimate of more than 290,000 cases of SSI,7 there is a substantial economic cost to the management of SSI. There is a wide variance in estimates of the attributable costs of SSI infection that depends heavily on the type of surgical procedure and the geographic region studied.98 There is additional

Summary

SSIs remain a very important component of patient outcome, contributing to substantial patient morbidity. From a historical perspective, there has been a significant improvement in postsurgical outcomes, but these incremental gains have slowed in the recent decades. The translation of basic and clinical research has expanded the complexity of evidence-based guidelines for SSI prevention. The importance of SSI prevention has been heightened because of its association with institutional and

First page preview

First page preview
Click to open first page preview

References (107)

  • A.M. Møller et al.

    Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial

    Lancet

    (2002)
  • T.W. Hakkarainen et al.

    Comparative effectiveness of skin antiseptic agents in reducing surgical site infections: a report from the Washington State Surgical Care and Outcomes Assessment Program

    J Am Coll Surg

    (2014)
  • P.S. Barie et al.

    Surgical site infections

    Surg Clin North Am

    (2005)
  • D.W. Bratzler et al.

    Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project

    Am J Surg

    (2005)
  • A.M. Eklund et al.

    Prophylaxis of sternal wound infections with gentamicin-collagen implant: randomized controlled study in cardiac surgery

    J Hosp Infect

    (2005)
  • O. Friberg et al.

    Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial

    Ann Thorac Surg

    (2005)
  • C. Schimmer et al.

    Gentamicin-collagen sponge reduces sternal wound complications after heart surgery: a controlled, prospectively randomized, double-blind study

    J Thorac Cardiovasc Surg

    (2012)
  • M.N. Mavros et al.

    Gentamicin collagen sponges for the prevention of sternal wound infection: a meta-analysis of randomized controlled trials

    J Thorac Cardiovasc Surg

    (2012)
  • F.W. Blaisdell

    Medical advances during the Civil War

    Arch Surg

    (1988)
  • M.M. Manring et al.

    Treatment of war wounds: a historical review

    Clin Orthop

    (2009)
  • A. Nespoli et al.

    The history of surgical infections

    Surg Infect (Larchmt)

    (2011)
  • R.M. Klevens et al.

    Estimating health care-associated infections and deaths in U.S. hospitals, 2002

    Public Health Rep

    (2007)
  • J.T. DiPiro et al.

    Infection in surgical patients: effects on mortality, hospitalization, and postdischarge care

    Am J Health Syst Pharm

    (1998)
  • V.D. Rosenthal et al.

    Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010

    Infect Control Hosp Epidemiol

    (2013)
  • D.H. Culver et al.

    Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System

    Am J Med

    (1991)
  • D.M. Sievert et al.

    Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010

    Infect Control Hosp Epidemiol

    (2013)
  • A.I. Hidron et al.

    NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

    Infect Control Hosp Epidemiol

    (2008)
  • National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986–April 1996, issued May 1996: A report from the National Nosocomial Infections Surveillance (NNIS) System

    Am J Infect Control

    (1996)
  • J.A. Jernigan

    Is the burden of Staphylococcus aureus among patients with surgical-site infections growing?

    Infect Control Hosp Epidemiol

    (2004)
  • D.J. Anderson et al.

    Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus

    Infect Control Hosp Epidemiol

    (2007)
  • R.J. Gorwitz et al.

    Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004

    J Infect Dis

    (2008)
  • G. Wang et al.

    Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period

    J Clin Microbiol

    (2006)
  • G. Steinkraus et al.

    Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05

    J Antimicrob Chemother

    (2007)
  • H.J. Adam et al.

    Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006

    Antimicrob Agents Chemother

    (2010)
  • R. Reynolds et al.

    Lack of upward creep of glycopeptide MICs for methicillin-resistant Staphylococcus aureus (MRSA) isolated in the UK and Ireland 2001-07

    J Antimicrob Chemother

    (2012)
  • H.S. Sader et al.

    Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006

    Antimicrob Agents Chemother

    (2009)
  • S.J. van Hal et al.

    Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates

    Antimicrob Agents Chemother

    (2011)
  • J.J. Engemann et al.

    Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection

    Clin Infect Dis

    (2003)
  • S.J. van Hal et al.

    Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections?

    Clin Infect Dis

    (2013)
  • D. Yong et al.

    Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India

    Antimicrob Agents Chemother

    (2009)
  • E.J. Hardy et al.

    Carbapenem-resistant Enterobacteriaceae containing New Delhi metallo-beta-lactamase in two patients - Rhode Island, March 2012

    MMWR Morb Mortal Wkly Rep

    (2012)
  • M.R. Mulvey et al.

    New Delhi metallo-beta-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada

    Emerg Infect Dis

    (2011)
  • L. Poirel et al.

    Emergence of metallo-beta-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia

    Antimicrob Agents Chemother

    (2010)
  • G. Zhou et al.

    NDM-1-producing strains, family Enterobacteriaceae, in hospital, Beijing, China

    Emerg Infect Dis

    (2014)
  • E.P. Barantsevich et al.

    Emergence of Klebsiella pneumoniae producing NDM-1 carbapenemase in Saint Petersburg, Russia

    J Antimicrob Chemother

    (2013)
  • P. Nordmann et al.

    Global spread of Carbapenemase-producing Enterobacteriaceae

    Emerg Infect Dis

    (2011)
  • M.J. Morowitz et al.

    The human microbiome and surgical disease

    Ann Surg

    (2011)
  • D.N. Frank et al.

    Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

    Proc Natl Acad Sci U S A

    (2007)
  • P. Seksik et al.

    Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon

    Gut

    (2003)
  • A.D. Olivas et al.

    Intestinal tissues induce an SNP mutation in Pseudomonas aeruginosa that enhances its virulence: possible role in anastomotic leak

    PLoS One

    (2012)
  • Cited by (0)

    Disclosures: No conflicts of interest to disclose.

    View full text